Fortis Healthcare board approves re-appointment of MD and CEO Dr. Raghuvanshi
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts less than Nifty Midcap 150 and 1.6 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Fortis Healthcare board on July 8, 2026 approved the re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director and CEO for a further two years effective March 19, 2027, subject to shareholder approval. His current term ends March 18, 2027. Dr. Raghuvanshi, aged about 64, is a cardiac surgeon with over 38 years of healthcare experience, including 18 plus years at Narayana Health. He is not debarred from the capital markets and is not related to any other director.
Continuity at the top. Shareholder approval is pending. No change in leadership, likely neutral to mildly positive for stability.